News & Updates
Filter by Specialty:

Antihypertensive drugs tied to HCC risk in MASLD with cirrhosis
27 Nov 2024
byStephen Padilla
Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and cirrhosis who are taking antihypertensive medications, including calcium channel blockers (CCBs) and angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), are at increased risk of developing hepatocellular carcinoma (HCC), suggests a study.
Antihypertensive drugs tied to HCC risk in MASLD with cirrhosis
27 Nov 2024
Hypo-, hyperthyroidism causally linked to pre-eclampsia
27 Nov 2024
Hyper- and hypothyroidism are causally associated with pre-eclampsia (PE), but PE does not causally influence thyroid dysfunctions, suggest the results of a Mendelian randomization (MR) study.